TCL Archive FDA’s Commitment To Cancer No Different Than Other Diseases, Kessler Tells Advocate August 14, 1992
TCL Archive CCOP RFA Response So Far Points To More Consortia Applications, Reasonable Geographic Distribution August 20, 1982
TCL Archive DeVita Accepts “Chop Lie” Cancer Control Elements In CCOP; RFA Delays Until After May NCAB Meeting March 12, 1982
TCL Archive Decisively Positive Swedish Study of PSA Becomes Focus of Debate Over Screening October 28, 2011
TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005
